Expression of progranulin (GP88) protein appears as an independent prognostic factor for clinical progression in high-risk prostate cancer patients

Abstract Prostate cancer (PCa), the second most common cancer, is still a major cause of morbidity and mortality among men worldwide. A particularly aggressive group of PCa, where prognostic biomarkers are still needed, are clinically defined high-risk PCa. We had previously shown that the survival...

Olles dieđut

Bibliográfalaš dieđut

Váldodahkkit:	Renata Dubrovska, Markus Eckstein, Rudolf Jung, Charis Kalogirou, Burkhard Kneitz, Martin Spahn, Marianna Kruithof-de Julio, Ginette Serrero, Binbin Yue, Carol Geppert, Robert Stöhr, Arndt Hartmann, Bernd Wullich, Verena Lieb, Helge Taubert, Sven Wach
Materiálatiipa:	Artigo
Giella:	Inglês
Almmustuhtton:	Nature Portfolio 2026-06-01
Ráidu:	Scientific Reports
Fáttát:	Prostate cancer Progranulin GP88 Immunohistochemistry Protein expression Clinical progression
Liŋkkat:	https://doi.org/10.1038/s41598-026-52197-0
Fáddágilkorat:	Lasit fáddágilkoriid Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!